Cameroon: Controversial AIDS treatment suspended

Cameroon said it was suspending tests of a controversial antiretroviral HIV/AIDS drug on prostitutes in Douala, the west African country's economic capital, citing failings in their implementation. The clinical trial was to determine whether Tenofovir, a drug sold under the name Viread by the US drug manufacturer Gilead, can prevent the human immunodeficiency virus (HIV) or AIDS.